Type II idiopathic macular telangiectasia and soft confluent drusen

被引:6
|
作者
Querques, Giuseppe [1 ]
Coscas, Gabriel [1 ]
Soubrane, Gisele [1 ]
Souied, Eric H. [1 ]
机构
[1] Univ Paris 12, Dept Ophthalmol, Ctr Hosp Intercommunal Creteil, F-94000 Creteil, France
关键词
Age-related macular degeneration; Drusen; Fluorescein angiography; Idiopathic macular telangiectasia; Spectral domain optical coherence tomography; Type 2a acquired idiopathic juxtafoveal retinal telangiectasis; JUXTAFOVEOLAR RETINAL TELANGIECTASIS; OPTICAL COHERENCE TOMOGRAPHY; THICKNESS;
D O I
10.1177/112067211002000234
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To describe the simultaneous presentation of soft confluent drusen and type 2 idiopathic macular telangiectasia (IMT) in both eyes of one patient. METHODS. A 79-year-old man with bilateral metamorphopsia and gradual reduction of central vision underwent a complete ophthalmologic examination. RESULTS. In this patient, fundus biomicroscopy revealed soft confluent drusen and a cystic appearance within the fovea, and fluorescein angiography (FA) showed late dye leakage. Interestingly, indocyanine green angiography (ICGA) showed absence of late hypercyanescence, and spectral domain optical coherence tomography (Spectralis SD-OCT) clearly revealed the presence of bilateral foveal cysts with thinning and loss of the normal architecture of the outer retina, as well as absence of retinal thickening within the parafoveolar area showing discrete late dye leakage on FA. Based on these findings, the patient was diagnosed with nonexudative age-related macular degeneration with foveal soft confluent drusen, and coincident nonproliferative type 2 IMT. CONCLUSIONS. To our knowledge, there is no previously reported case of simultaneous presentation of soft confluent drusen and type 2 IMT. This report highlights the importance of ICGA and OCT in the correct diagnosis of such cases. (Eur J Ophthalmol 2010; 20: 466-8)
引用
收藏
页码:466 / 468
页数:3
相关论文
共 50 条
  • [1] Laser photocoagulation of confluent soft macular drusen
    Boscia, F
    Ferrari, TM
    Durante, G
    Cardia, L
    [J]. OPHTHALMOLOGY, 1998, 105 (05) : 760 - 761
  • [2] Laser photocoagulation of confluent soft macular drusen - Reply
    Little, HL
    [J]. OPHTHALMOLOGY, 1998, 105 (05) : 761 - 761
  • [3] BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II
    Kovach, Jaclyn L.
    Rosenfeld, Philip J.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (01): : 27 - 32
  • [4] Management of Idiopathic Macular Telangiectasia Type 2
    Alireza Khodabande
    Ramak Roohipoor
    Javad Zamani
    Masoud Mirghorbani
    Hamidreza Zolfaghari
    Shahab Karami
    Bobeck S. Modjtahedi
    [J]. Ophthalmology and Therapy, 2019, 8 : 155 - 175
  • [5] Bevacizumab and type 1 idiopathic macular telangiectasia
    C L Koay
    F L M Chew
    S Visvaraja
    [J]. Eye, 2011, 25 : 1663 - 1665
  • [6] Management of Idiopathic Macular Telangiectasia Type 2
    Khodabande, Alireza
    Roohipoor, Ramak
    Zamani, Javad
    Mirghorbani, Masoud
    Zolfaghari, Hamidreza
    Karami, Shahab
    Modjtahedi, Bobeck S.
    [J]. OPHTHALMOLOGY AND THERAPY, 2019, 8 (02) : 155 - 175
  • [7] A pilot randomized controlled study on the effect of laser photocoagulation of confluent soft macular drusen
    Little, HL
    Showman, JM
    Brown, BW
    [J]. OPHTHALMOLOGY, 1997, 104 (04) : 623 - 631
  • [8] Bevacizumab and type 1 idiopathic macular telangiectasia
    Koay, C. L.
    Chew, F. L. M.
    Visvaraja, S.
    [J]. EYE, 2011, 25 (12) : 1663 - 1665
  • [9] Idiopathic macular telangiectasia
    Yannuzzi, LA
    Bardal, AMC
    Freund, KB
    Chen, KJ
    Eandi, CM
    Blodi, B
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (04) : 450 - 460
  • [10] Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia
    Helb, Hans-Martin
    Issa, Peter Charbel
    Van der Veen, Rob L. P.
    Berendschot, Tos T. J. M.
    Scholl, Hendrik P. N.
    Holz, Frank G.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (06): : 808 - 816